Clinically proven

In a prospective clinical study of 123 patients at a leading US Hospital system using the MSIS-13 criteria as comparator, the Lyfstone Calprotectin test showed excellent sensitivity (98.1%) and specificity (95.7%). The calprotectin test outperformed blood-based PJI diagnostic tests such as CRP and ESR, confirming its diagnostic utility.

Source: Diagnostic Utility of a Novel Point-of-Care Test of Calprotectin for Periprosthetic Joint Infection after Total Knee Arthroplasty: A Prospective Cohort Study.

A new advancement in diagnosing PJI

The Lyfstone Calprotectin POC test is a new, advanced diagnostic aid that helps orthopaedic surgeons make better informed decisions, faster and more accurately. It’s easy to use and identifies the risk of periprosthetic joint infection (PJI) in 15 minutes.